Periferna arterijska bolezen (Slovenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Periferna arterijska bolezen" in Slovenian language version.

refsWebsite

Global rank Slovenian rank

18nih.gov

4^th place

8^th place

10doi.org

2^nd place

5^th place

1web.archive.org

1^st place

2^nd place

1heart.org

8,639^th place

1,757^th place

doi.org

Violi, F; Basili, S; Berger, JS; Hiatt, WR (2012). »Antiplatelet therapy in peripheral artery disease«. Handbook of experimental pharmacology. Št. 210. str. 547–63. doi:10.1007/978-3-642-29423-5_22. PMID 22918746.
Fowkes, FG; Rudan, D; Rudan, I; Aboyans, V; Denenberg, JO; McDermott, MM; Norman, PE; Sampson, UK; Williams, LJ (19. oktober 2013). »Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis«. Lancet. Zv. 382, št. 9901. str. 1329–40. doi:10.1016/s0140-6736(13)61249-0. PMID 23915883.
Ruiz-Canela, M; Martínez-González, MA (2014). »Lifestyle and dietary risk factors for peripheral artery disease«. Circulation Journal. Zv. 78, št. 3. str. 553–9. doi:10.1253/circj.cj-14-0062. PMID 24492064.
Andras, A; Ferket, B (7. april 2014). »Screening for peripheral arterial disease«. The Cochrane database of systematic reviews. Zv. 4. str. CD010835. doi:10.1002/14651858.CD010835.pub2. PMID 24711093.
Fokkenrood, HJ; Bendermacher, BL; Lauret, GJ; Willigendael, EM; Prins, MH; Teijink, JA (23. avgust 2013). »Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication«. The Cochrane database of systematic reviews. Zv. 8. str. CD005263. doi:10.1002/14651858.CD005263.pub3. PMID 23970372.
Hankey, GJ; Norman, PE; Eikelboom, JW (1. februar 2006). »Medical treatment of peripheral arterial disease«. JAMA. Zv. 295, št. 5. str. 547–53. doi:10.1001/jama.295.5.547. PMID 16449620.
Bedenis, R; Stewart, M; Cleanthis, M; Robless, P; Mikhailidis, DP; Stansby, G (31. oktober 2014). »Cilostazol for intermittent claudication«. The Cochrane database of systematic reviews. Zv. 10. str. CD003748. doi:10.1002/14651858.CD003748.pub4. PMID 25358850.
Lin, JS; Olson, CM; Johnson, ES; Whitlock, EP (3. september 2013). »The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force«. Annals of Internal Medicine. Zv. 159, št. 5. str. 333–41. doi:10.7326/0003-4819-159-5-201309030-00007. PMID 24026319.
Poredos, P; Jezovnik, MK (Marec 2013). »Is aspirin still the drug of choice for management of patients with peripheral arterial disease?«. VASA. Zeitschrift für Gefasskrankheiten. Zv. 42, št. 2. str. 88–95. doi:10.1024/0301-1526/a000251. PMID 23485835.
Naghavi, Mohsen; in sod. (GBD 2013 Mortality and Causes of Death Collaborators) (17. december 2014). »Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013«. Lancet. Zv. 385, št. 9963. str. 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

heart.org

»What Is Peripheral Vascular Disease?« (PDF). American Heart Association. 2012. Arhivirano iz prvotnega spletišča (PDF) dne 12. aprila 2015. Pridobljeno 26. februarja 2015.

nih.gov

pubmed.ncbi.nlm.nih.gov

Violi, F; Basili, S; Berger, JS; Hiatt, WR (2012). »Antiplatelet therapy in peripheral artery disease«. Handbook of experimental pharmacology. Št. 210. str. 547–63. doi:10.1007/978-3-642-29423-5_22. PMID 22918746.
Fowkes, FG; Rudan, D; Rudan, I; Aboyans, V; Denenberg, JO; McDermott, MM; Norman, PE; Sampson, UK; Williams, LJ (19. oktober 2013). »Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis«. Lancet. Zv. 382, št. 9901. str. 1329–40. doi:10.1016/s0140-6736(13)61249-0. PMID 23915883.
Ruiz-Canela, M; Martínez-González, MA (2014). »Lifestyle and dietary risk factors for peripheral artery disease«. Circulation Journal. Zv. 78, št. 3. str. 553–9. doi:10.1253/circj.cj-14-0062. PMID 24492064.
Andras, A; Ferket, B (7. april 2014). »Screening for peripheral arterial disease«. The Cochrane database of systematic reviews. Zv. 4. str. CD010835. doi:10.1002/14651858.CD010835.pub2. PMID 24711093.
U.S. Preventive Services Task Force (15. december 2014). »Peripheral artery disease screening and cardiovascular disease risk assessment with the ankle-brachial index in adults: recommendation statement«. Am Fam Physician. Zv. 90, št. 12. str. 858A–858D. PMID 25591190.
Fokkenrood, HJ; Bendermacher, BL; Lauret, GJ; Willigendael, EM; Prins, MH; Teijink, JA (23. avgust 2013). »Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication«. The Cochrane database of systematic reviews. Zv. 8. str. CD005263. doi:10.1002/14651858.CD005263.pub3. PMID 23970372.
Hankey, GJ; Norman, PE; Eikelboom, JW (1. februar 2006). »Medical treatment of peripheral arterial disease«. JAMA. Zv. 295, št. 5. str. 547–53. doi:10.1001/jama.295.5.547. PMID 16449620.
Bedenis, R; Stewart, M; Cleanthis, M; Robless, P; Mikhailidis, DP; Stansby, G (31. oktober 2014). »Cilostazol for intermittent claudication«. The Cochrane database of systematic reviews. Zv. 10. str. CD003748. doi:10.1002/14651858.CD003748.pub4. PMID 25358850.
Lin, JS; Olson, CM; Johnson, ES; Whitlock, EP (3. september 2013). »The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force«. Annals of Internal Medicine. Zv. 159, št. 5. str. 333–41. doi:10.7326/0003-4819-159-5-201309030-00007. PMID 24026319.
Poredos, P; Jezovnik, MK (Marec 2013). »Is aspirin still the drug of choice for management of patients with peripheral arterial disease?«. VASA. Zeitschrift für Gefasskrankheiten. Zv. 42, št. 2. str. 88–95. doi:10.1024/0301-1526/a000251. PMID 23485835.
Hauk, L (15. maj 2012). »ACCF/AHA update peripheral artery disease management guideline«. American family physician. Zv. 85, št. 10. str. 1000–1. PMID 22612053.
Naghavi, Mohsen; in sod. (GBD 2013 Mortality and Causes of Death Collaborators) (17. december 2014). »Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013«. Lancet. Zv. 385, št. 9963. str. 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

nhlbi.nih.gov

»What Is Peripheral Arterial Disease?«. Nacionalni inštitut za srce, pljuča in kri. 2. avgust 2011. Pridobljeno 25. februarja 2015.
»What Are the Signs and Symptoms of Peripheral Arterial Disease?«. Nacionalni inštitut za srce, pljuča in kri. 2. avgust 2011. Pridobljeno 26. februarja 2015.
»What Causes Peripheral Arterial Disease?«. Nacionalni inštitut za srce, pljuča in kri. 2. avgust 2011. Pridobljeno 26. februarja 2015.
»How Is Peripheral Arterial Disease Diagnosed?«. 2. avgust 2011. Pridobljeno 27. marca 2015.
»How Is Peripheral Arterial Disease Treated?«. Nacionalni inštitut za srce, pljuča in kri. 2. avgust 2011. Pridobljeno 26. februarja 2015.

ncbi.nlm.nih.gov

Naghavi, Mohsen; in sod. (GBD 2013 Mortality and Causes of Death Collaborators) (17. december 2014). »Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013«. Lancet. Zv. 385, št. 9963. str. 117–71. doi:10.1016/S0140-6736(14)61682-2. PMC 4340604. PMID 25530442.

web.archive.org

»What Is Peripheral Vascular Disease?« (PDF). American Heart Association. 2012. Arhivirano iz prvotnega spletišča (PDF) dne 12. aprila 2015. Pridobljeno 26. februarja 2015.